Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

NCT01482728 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Dasatinib
DRUG: Dasatinib

Sponsor

University of Virginia